Ferk Franziska, Gminski Richard, Al-Serori Halh, Mišík Miroslav, Nersesyan Armen, Koller Verena J, Angerer Verena, Auwärter Volker, Tang Tao, Arif Ali Talib, Knasmüller Siegfried
Department of Internal Medicine 1, Institute of Cancer Research, Medical University of Vienna, Borschkegasse 8A, 1090, Vienna, Austria.
Environmental Health Sciences and Hospital Infection Control, Medical Center, University of Freiburg, 79106, Freiburg, Germany.
Arch Toxicol. 2016 Dec;90(12):3111-3123. doi: 10.1007/s00204-016-1664-4. Epub 2016 Feb 8.
Aim of this study was the investigation of the genotoxic properties of XLR-11 1-(5-fluoropentyl)-1H-indol-3-ylmethanone, a widely consumed synthetic cannabinoid (SC), and of the benzoyl indole RCS-4 (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone). We characterized the DNA-damaging properties of these drugs in different experimental systems. No evidence for induction of gene mutations was detected in bacterial (Salmonella/microsome) tests, but clear dose-dependent effects were found in in vitro single cell gel electrophoresis (SCGE) assays with human lymphocytes and with buccal- and lung-derived human cell lines (TR-146 and A-549). These experiments are based on the determination of DNA migration in an electric field and enable the detection of single- and double-strand breaks and apurinic sites. Furthermore, we found that both drugs induce micronuclei which are formed as a consequence of chromosomal aberrations. The lack of effects in SCGE experiments with lesion-specific enzymes (FPG, Endo III) shows that the DNA damage is not caused by formation of oxidatively damaged bases; experiments with liver enzyme homogenates and bovine serum albumin indicate that the drugs are not converted enzymatically to DNA-reactive intermediates. Furthermore, results with buccal- and lung-derived human cells show that gaseous treatment of the cells under conditions which reflect the exposure situation in drug users may cause damage of the genetic material in epithelia of the respiratory tract. Since DNA instability is involved in the etiology of cancer, these findings can be taken as an indication that consumption of the SCs may cause tumors in the respiratory tract of consumers.
本研究旨在调查XLR-11 1-(5-氟戊基)-1H-吲哚-3-基甲酮(一种广泛使用的合成大麻素(SC))以及苯甲酰吲哚RCS-4((4-甲氧基苯基)(1-戊基-1H-吲哚-3-基)甲酮)的遗传毒性特性。我们在不同的实验系统中对这些药物的DNA损伤特性进行了表征。在细菌(沙门氏菌/微粒体)试验中未检测到基因突变诱导的证据,但在用人淋巴细胞以及口腔和肺来源的人细胞系(TR-146和A-549)进行的体外单细胞凝胶电泳(SCGE)试验中发现了明显的剂量依赖性效应。这些实验基于电场中DNA迁移的测定,能够检测单链和双链断裂以及脱嘌呤位点。此外,我们发现这两种药物都会诱导微核形成,微核是染色体畸变的结果。在使用损伤特异性酶(FPG、Endo III)的SCGE实验中未发现效应,这表明DNA损伤不是由氧化损伤碱基的形成引起的;用肝酶匀浆和牛血清白蛋白进行的实验表明,这些药物不会通过酶促转化为具有DNA反应性的中间体。此外,来自口腔和肺的人细胞的实验结果表明,在反映吸毒者接触情况的条件下对细胞进行气态处理可能会导致呼吸道上皮细胞中的遗传物质受损。由于DNA不稳定性与癌症病因有关,这些发现可以被视为表明食用这些合成大麻素可能会在消费者的呼吸道中引发肿瘤。